MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • A 6-month Pilot Study of Disease-Modifying Potential of Long-term Transcutaneous Auricular Vagus Nerve Stimulation in Parkinson’s Disease

    JX. Shi, KZ. Zhang (Nanjing, China)

  • A biomarker of Huntington’s disease progression derived from deep neural speech representations

    C. Le Moine, AC. Bachoud-Lévi, R. Massart, R. Louiset (Creteil, France)

  • A Brief Clinical Test Battery Predicting UPDRS II Disability in Parkinson Disease

    R. Dias, G. Santos, P. Silva, M. Pimentel Piemonte (São Paulo, Brazil)

  • A Case of Anti-NMDA Receptor Encephalitis Presenting with Refractory Myoclonus and Perioral Dyskinesia during the First Trimester of Pregnancy

    TK. Yoon, SY. You (Seoul, Republic of Korea)

  • A case of difficulty extubating after General Anesthesia Deep Brain Stimulation (DBS) surgery

    KW. Chen, JJ. Lin, WC. Chou, PY. Chiu, CS. Chang (Taichung, Taiwan)

  • A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson’s disease symptoms

    C. Moreau, F. Marchand, J. Bene, C. Leclercq, V. Foutel, M. Fisichella, D. Devos (Lille, France)

  • A Case of NUS1 Spectrum Disorder with Adult-Onset Psychosis

    D. Fishbein, S. Adler, J. Ng, M. Ferris (Palo Alto, USA)

  • A Case of Progressive Cerebellar Syndrome with Ataxia as a First Sign

    J. Mateo, A. Tamayo (Callao, Peru)

  • A Case of Rapidly Evolving Ataxic Syndrom in a Young Adult

    J. Mateo, A. Beteta (Callao, Peru)

  • A Case report of Progressive Supranuclear Palsy with Cerebellar Ataxia and Chorea

    D. Fishbein, S. Barton, J. Ng, M. Ferris (Palo Alto, USA)

  • A Case Report: Optimising Motor and Non-Motor Control in Advanced Parkinson’s Disease: The Role of Foslevodopa/Foscarbidopa After Deep Brain Stimulation

    J. Wong, S. Williams, M. Lubomski (St Leonards, Australia)

  • A case series of Spinocerebellar ataxia subtype 15 from Chile

    M. Niedbalski, M. Canals, F. Urbina, M. Leon, S. de Almorzara, M. Sánchez, M. Miranda (Santiago, Chile)

  • A Cerner-based Electronic Prescribing and Medicines Administration (EPMA) Parkinson’s Medicines Care Plan Reduces Time-Critical Medication (TCM) Errors.

    T. Lessware, R. Lal, M. Andrews, D. Trivedi, J. Mathews, E. Bhadra, C. Budu, D. Gallagher, A. Noyce, T. Boyle (London, United Kingdom)

  • A Clinical Mapping Framework for Motor Balance Impairment in Welders Projected Against Parkinson Disease Severity Stages

    S. Narayanan, A. Alkinani, S. Ramesh, M. Thyagarajan, V. Krishnan Muthaiah (Buffalo, USA)

  • A Comparison of Video-Based and Sensor-Based Movement Measurements in Cervical Dystonia

    O. Killian, S. Jimenez, A. Gill, C. Fearon, L. Williams, S. O'Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)

  • A composite oculomotor biomarker for differentiating Parkinson’s disease from multiple system atrophy

    M. Wójcik-Pędziwiatr, D. Hemmerling, J. Sikora, J. Stępień, W. Szecówka, M. Baran, M. Rudzińska-Bar (Kraków, Poland)

  • A Comprehensive Analysis of Advanced Deep Brain Stimulation Programming Strategies

    P. Gupta, P. Graese, R. Burke, P. Zeilman, J. Wong (Gainesville, USA)

  • A CSF C Terminal α Synuclein Assay to Differentiate Multiple System Atrophy From Parkinson’s Disease

    P. Kallunki, L. Hansen, J. Wiedemann, L. Rørbæk Olsen, F. Schalk, N. van Demerbel (Valby, Denmark)

  • A Cumulative Genetic Risk Score Predicts Progression in Parkinson’s Disease: 5-year longitudinal study from The Early Parkinson’s disease Longitudinal Singapore (PALS) cohort

    DX. Deng, LT. Tan, TEK. Tan (Singapore, Singapore)

  • A Deep Learning Model-based Screening System for Nystagmus in Central Vertigo

    H. Takeda, K. Eguchi, S. Shirai, H. Yaguchi, K. Fujiwara, I. Yabe (Sapporo, Japan)

  • A Diffusion MRI Neurodegeneration Index for Lewy Body Dementia & Alzheimer’s disease

    S. Chiu, R. Chen, W. Wang, J. Desimone, A. Barmpoutis, M. Armstrong, D. Vaillancourt (Scottsdale, USA)

  • A Digital Toolkit for Movement Disorders Clinicians

    A. Lin, J. Patino, B. Talavera, Z. Yu, G. Brawerman, A. Koppanatham, C. Terrazas-Gamboa, A. Mahajan (Cincinnati, USA)

  • A Distinct Genetic Landscape of Progressive Supranuclear Palsy in Asians: Beyond the MAPT-Dominant Paradigm

    P. Chen, R. Lin, H. Chen, W. Luo, H. Chiang, C. Chen, Y. Wu, Y. Chang, C. Lu, H. Kim, G. Saranza, T. Nomura, H. Yaguchi, W. Lee, A. Tan, E. Tan, C. Chan, I. Yabe, S. Lim, C. Lin (Taipei, Taiwan)

  • A Dopamine Clock for Biological Staging of Parkinson’s Disease

    R. Gunn, G. Searle, G. Rizzo, Z. Fan, T. Tropea, T. Simuni, K. Poston, A. Siderowf, L. Chahine, J. Seibyl, K. Marek (London, United Kingdom)

  • A Genome-Wide Search for Common Variants Modifying Age at Onset in PRKN-Associated Parkinson’s Disease

    PJ. Menon, C. Tesson, F. Casse, M. Ferrien, F. Magrinelli, H. Houlden, J. Aasly, A. Di Fonzo, A. Brice, S. Lesage, J. Corvol (Paris, France)

  • A highly specific skin α-synuclein seed amplification assay for screening of synucleionpathies

    Y. Ma, S. Weber, C. Farris, S. Schnell, J. Kalinkara-Gomez, S. Rosete-Gonzalez, D. Murphy, B. Mollenhauer, L. Concha (San Diego, USA)

  • A Large-Scale Digital Parkinson Disease Platform Matches Clinician Identification of Dyskinesia and Uncovers Unmet Need Between Visits

    A. Hare, B. Hood, S. Shaffer, R. Gilron (San Francisco, USA)

  • A Longitudinal Case of Adult-Onset Progressive Ataxia in a Patient with a Pathogenic Variant of IRF2BPL

    S. de Groot, W. Rai (Sioux Falls, USA)

  • A Machine Learning-Based Approach to Identify Responders to Electrosonic Brain Stimulation in Parkinson’s Disease

    L. Dipietro, U. Eden, S. Elkin-Frankston, M. El-Hagrassy, D. Doruk Camsari, C. Ramos-Estebanez, F. Fregni, T. Wagner (Cambridge, USA)

  • A Meta-analysis of Tonic Motor Activation (TOMAC) Therapy for Restless Legs Syndrome

    J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

  • A Methodological Framework for Selecting Digital Gait Outcomes in Clinical Trials

    V. Shah, J. Mcnames, H. Casey, R. Rodriguez-Labrada, L. Velázquez-Pérez, F. Horak, C. Gomez (Philadelphia, USA)

  • A National Interprofessional Model for Parkinson’s Disease Education: Over 20 Years of Collaborative Learning Across the Veterans Health Administration

    E. Wong, A. Li Wong, G. Glenn (San Francisco, USA)

  • A Novel Bedside Clinical Test (“Vibration” Sign) Improves Diagnostic Differentiation of Functional Movement Disorders: A Prospective Pilot Study

    D. Garg, F. Mustafa, A. Agarwal, V. Patil, A. Srivastava (New Delhi, India)

  • A Novel Case of Persistent Singing in Progressive Supranuclear Palsy

    F. Chinea, U. Akbar (Hackensack, USA)

  • A Novel Clinical Protocol for Monitoring Therapeutic Outcomes in Camptocormia in Parkinson´s Disease

    L. Lundh, E. Franzén, S. Grigoriou, M. Söderholm, W. Duzynski, F. Strömqvist, B. Lindholm (Ängelholm, Sweden)

  • A Novel Genome Editing Strategy for Permanent and Precise Downregulation of α-Synuclein in Parkinson’s Disease

    B. Manohar, R. Wilson (Berkeley, USA)

  • A Novel Homozygous Variant in MYORG is Associated with Primary Brain Calcification and Paroxysmal Dyskinesia

    Y. Guo, L. Wang, X. Wang, Z. Cen, W. Luo (Zhejiang, China)

  • A Novel Hyperkinetic–Cerebellar Phenotype with Subependymal Nodules in Glutaric Acidemia Type 1

    D. Avecilla-Bonilla, K. Salinas-Barboza, D. Ramírez álvarez, L. Salinas-Yañez, J. Altamirano (Mexico, Mexico)

  • A Novel paradigm for the recording of col-cap movements and muscle activity in Cervical Dystonia

    O. Killian, S. Jimenez, A. Gill, C. Fearon, L. Williams, S. O'Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)

  • A novel pro-drug overcomes short-half life and absorption challenges and increase brain penetration of dopamine as a potential therapy for Parkinson’s disease

    C. Moussa (Washington DC, USA)

  • A Novel SPG11 Splice-Site Mutation in Hereditary Spastic Paraplegia: Clinical, Radiologic, and Genetic Insights from the First Philippine Case

    E. Naoe (Manila, Philippines)

  • A Novel Therapeutic Targeting the tPA-NMDAr Interaction for Multiple System Atrophy

    N. Delétage, F. Lesept, A. Henriques, N. Callizot, E. Bezard, M. Blanc (Lyon & Caen, France)

  • A Novel VAC14 Variant Associated With Levodopa-responsive Generalized Dystonia

    G. Urciuolo, J. Yomtoob, T. Fonseca, T. Abramova, L. Kinsley, L. Verhagen, N. Mencacci (Rome, Italy)

  • A Patient-Directed AI-Enabled Platform for Continuous Personalised Parkinson’s Management

    E. Meinert, J. Schivers, A. Ananthakrishnan, C. Carroll (Newcastle, United Kingdom)

  • A Phase 1b Study to Investigate Safety, Tolerability and Biomarker Responses of Repeated Subcutaneous Doses of HER-096 in Subjects with Parkinson’s Disease

    K. Holmström, K. Jääskeläinen, N. Kulesskaya, A. Ludwig, J. Koskinen, A. Vuolanto, A. Domanska, M. Engström, S. Määttänen, P. Vainio, M. Scheinin, C. Videbaek, Z. Lovro, F. Scheperjans, J. Rinne, H. Huttunen (Espoo, Finland)

  • A Phase 3, Multinational, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial (IB1001-304) Evaluating Levacetylleucine in CACNA1A Disorders

    B. Zanrucha, T. Bremova-Ertl, M. Patterson, M. Strupp, J. Kerthi, J. Raymond, T. Fields, I. Billington, K. Martakis (Austin, USA)

  • A Phase I Multicenter Trial of a Novel Gene Therapy BBM-P002 for Parkinsons Disease

    M. Niu, J. Lin, J. Liu (Shanghai, China)

  • A Pilot Study of Phosphorylated Alpha-Synuclein Detection and Quantitation from Routine Colonic Biopsies in Patients with Parkinson’s disease

    T. Levine, R. Freeman, B. Bellaire, J. Parent, S. Marcotte, M. Duval, C. Gibbons (scottsdale, USA)

  • A Pragmatic Phenotype-Guided Algorithm for Constipation in Parkinson’s Disease

    G. Hey, M. Beke, C. Rogers, A. Ramirez-Zamora, M. Amaris (Gainesville, USA)

  • A prospective single-center study investigating the utility of supportive features in the diagnosis of multiple system atrophy with predominant cerebellar ataxia

    A. Sugiyama, Y. Nakagawa, M. Namiki, S. Hirano, Y. Nakano, T. Yamamoto, Y. Yamanaka, M. Mori (Chiba, Japan)

  • A Randomized Controlled Trial Evaluating Ankle Pump Combined with Compression Abdominal Belts on Orthostatic Hypotension in Patients with Parkinson’s Disease

    Z. Ruan, YY. Zhang, WH. Guo, JY. Liu (Beijing, China)

  • A Rare Case of PLA2G6 Gene Related Early-Onset Dystonia-Parkinsonism; What Not to Miss Clinically and Radiologically

    Y. Degirmenci (Istanbul, Turkey)

  • A Real World Case Series of the Nidra Transcutaneous Afferent Patterned Stimulation Device in Moderate-to-Refractory Restless Legs Syndrome

    N. Hellmers, H. Ooi, A. Yoo, H. Sarva (New York, USA)

  • A retrospective Chart Review of Clinical and Demographic Patterns in Essential Tremor

    S. Ibrahim, S. Bano, R. Saini, S. Philip, B. Mohamed, S. Page (Cardiff, United Kingdom)

  • A Retrospective Cohort-Based Construction of a Risk Prediction Model for Anxiety or Depression in Parkinson’s Disease and Analysis of Acupuncture Exposure Effects

    W. Yixuan, L. Xin, X. Liangman, L. Shumin, Z. Fan, Z. Lixing (Guangzhou, China)

  • A Retrospective Comparison of Multiple Approaches to LFP-guided and Imaging Guided Contact Selection in Subthalamic Deep Brain Stimulation for Parkinson’s Disease

    SH. Herstell, CST. Schedlich-Teufer, ES. Schmehr, JS. Strelow, GB. Brandt, VVV. Visser-Vandewalle, TD. Dembek, MB. Barbe (Cologne, Germany)

  • A Retrospective Study Of Outcomes Of Deep Brain Stimulation In Juvenile Parkinson’s Disease.

    I. Goyal, P M. Wadia, P. Doshi (Mumbai, India)

  • A Retrospective Video Review Of Functional Movement Disorders (FMD)

    I. Goyal, P M. Wadia (Mumbai, India)

  • A Severe Parkinsonism Revealing Neurosarcoidosis : A Case Report

    R. Zouari, L. Hlioui, F. Nabli, MZ. Saied, S. Ben Sassi (Tunis, Tunisia)

  • A Specialized 3D-Printed Device for Gait Rehabilitation in Parkinson’s: Development and Application.

    S. Ismailova, S. Prokopenko (Krasnoyarsk, Russian Federation)

  • A Specific Neuronal Subpopulation in Globus Pallidus External Segment Mediates the Pathogenesis of Dyskinesia in Parkinson’s Disease

    C. Shen (Shanghai, China)

  • A Structured Multidisciplinary Pathway for the Management of Complex Patients Following Deep Brain Stimulation

    C. Ballester, F. Khalil, M. Mohamad, H. Akram, L. Zrinzo, J. Hyam, T. Foltynie, P. Limousin, M. Krueger, S. Xu (London, United Kingdom)

  • A Switching from Oral Donepezil to a Twice-Weekly Korean Transdermal Donepezil Patch in Patients with Dementia with PD

    M. Park, J. An (Daegu, Democratic People's Republic of Korea)

  • A Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fluid Biomarkers in Parkinson’s Disease

    STT. Nguyen, J. Ruiz Tejeda, D. Tran, R. Rajmohan, N. Phielipp (Irvine, USA)

  • A Systematic Review and Meta-Analysis on Cognitive and Behavioral Impairments in Primary Tauopathies

    K. Burgos, F. Castaño, F. Rodrigues, L. Di Luca, B. Couto, M. Roca (CABA, Argentina)

  • A Therapeutic Approach to Writer’s Cramp-Type Focal Dystonia Using Botulinum Toxin: Experience of the Neurology/Movement Disorders Department of the Hospital do Servidor Público de São Paulo

    K. Alves, T. Gonçalves, B. Dias, R. Pinto, E. Souto, D. Faria, S. Gomes (Sao Paulo, Brazil)

  • A Tiered Fecal Biomarker Approach to Identify Gut–Brain Axis Phenotypes in Young-Onset Parkinsonism in a Clinical Setting with Limited Resources

    N. Raisa, F. Aushi (Malang, Indonesia)

  • Abdominal Binders to treat Orthostatic Hypotension in Parkinsonian Syndromes

    F. Leys, N. Campese, V. Sidoroff, F. Terranova, B. Caliò, K. Gotwald, G. Saccardin, K. Marini, M. Peball, C. Raccagni, H. Stockner, B. Bloem, R. Granata, S. Kiechl, J. Klucken, B. Metzler, W. Poewe, K. Seppi, R. Thijs, S. Sapienza, G. Goebel, G. Wenning, A. Fanciulli (Innsbruck, Austria)

  • About Data Missingness in Wearable Monitoring of Parkinson’s Disease

    E. Roveroni, M. Moretto, A. Giupponi, M. Castellaro, T. Gandolfi, M. Veronese (Padova, Italy)

  • Accelerated brain iron accumulation secondary to hypoxia in a patient with hereditary haemochromatosis with homozygous C282Y mutations.

    A. Chakraborty, D. Gallagher, C. Simonet, N. Gorgoraptis (London, United Kingdom)

  • Accelerating the Implementation of Network-based Care for Parkinson’s Disease (ACTION-PD)

    M. Meinders, J. Swillens, A. Antonini, O. Rascol, K. Smilowska, P. Calabresi, M. Steppe, B. Bloem, M. Munneke (Nijmegen, Netherlands)

  • Acceptability and feasibility of digital mobility assessment for Parkinson’s Disease: Perspectives from people with Parkinson’s, carers and health and social care professionals in Ghana and Kenya

    R. Mc Ardle, J. Lumsdon, B. Mghendi, E. Ame-Bruce, W. Animdife, M. Agoriwo, M. Cham, A. Akpalu, S. Del Din, L. Rochester, K. Brittain, R. Walker, N. Fothergill-Misbah (Newcastle upon Tyne, United Kingdom)

  • Access to rehabilitation therapy for people with Parkinson’s disease in Rome, Italy

    G. Di Lazzaro, D. Genovese, AT. Cimmino, P. Zinzi, AR. Bentivoglio, P. Calabresi (Rome, Italy)

  • Accessible Assessment of Ataxia Severity Across Diverse Populations: Integrating Large Datasets, Machine-Learning, and Online Testing

    T. Gilad, A. Lithwick Algon, S. Yamnitsky, P. Ponger, J. Hausdorff, W. Saban (Tel Aviv, Israel)

  • Acquired Hemidystonia as a Manifestation of Primary Antiphospholipid Syndrome in a Young Adult

    N. Abdelall, R. Herrera-Noriega, C. Taylor, N. Alshaer, S. Perez (New Orleans, USA)

  • Acrostic for the differential diagnosis of atypical Parkinsonian

    L. Ortega-Bolaños, V. Martinez-Villota, E. Gatto, D. Bolaños Ortega, K. Ortega Dorado, C. Hurtado Gonzalez, J. Fernandez Boccazzi (CALI, Colombia)

  • Activation of the MT1 Receptor Ameliorates Mitochondrial Dysfunction in MPP+/MPTP-Induced Parkinson’s Disease

    LL. Qi, CF. Liu, F. Wang (Suzhou, China)

  • Active Contact Localization in the Subthalamic Nucleus Predicts Phonemic Fluency Decline After Bilateral STN-DBS

    š. Janovič, S. Hollý, B. Al-Fatly, P. Zvarová, M. Kľoc, T. Harag, M. Chmelík, D. Juskanič, L. Hapáková, A. Kušnírová, B. Gaštanová, Z. Košutzká (Bratislava, Slovakia)

  • Acupuncture Combined with Anti-Parkinson Medication Improves Objective Balance Parameters in Patients with Parkinson’s Disease

    X. Liu, Q. Liu, SM. Lin, MY. Yan, YX. Wu, JQ. Fan, YF. Zhang, LX. Zhuang (Guangzhou, China)

  • Acute administration of methylphenidate modulates functional connectivity during the processing of irrelevant stimuli in Parkinson’s disease patients

    N. Fogelson, L. Li, B. Tan, E. Martinez Lopez, M. Roson Gonzalez, M. Fernandez Delolmo, T. Gurevich, L. Vela Desojo (Fuenlabrada, Spain)

  • Acute Hemichorea as a Rare Presentation of Right Temporoparietal Infarction: A Case Report

    SJ. Ahn, SY. You (Seoul, Republic of Korea)

  • Acute Microstructural Imaging of Focused Ultrasound Thalamotomy Lesions is Associated with Long-Term Tremor Relief in Essential Tremor

    C. Sanchez-Catasus, G. Serna Requejo, L. Gonzalez-Quarante, A. Gorospe, B. Garate Andikoetxea, I. Aviles-Olmos, A. Arcadi, A. Martin-Bastida, J. Guridi, M. Rodriguez-Oroz (Pamplona, Spain)

  • Adaptive Deep Brain Stimulation Guided by Electrophysiological Mapping for Stimulation-Induced Gluteal Dystonia in Parkinson’s Disease

    K. Adabi, R. Ash, M. Sedrak (Oakland, USA)

  • Adaptive Deep Brain Stimulation in Parkinson Disease: Preliminary Single-Center Results

    C. Gonzalez-Robles, M. Mancuso, J. Candelario-Mckeown, M. Krueger, H. Akram, L. Zrinzo, T. Foltynie, S. Xu, P. Limousin (London, United Kingdom)

  • Adaptive Subthalamic Nucleus Deep Brain Stimulation (aDBS) for Refractory Dyskinesia in Parkinson’s Disease: A Case Report of Two Patients

    C. Lau, V. Tang, A. Chan, L. Au, K. Ma, T. Mok, J. Yeung, L. Cheung, C. Zhu, D. Chan, V. Mok (Hong Kong, Hong Kong)

  • Added Value of Wearable-Derived Gait Features Beyond Clinical Assessments in Parkinson’s Disease

    R. Weijer, V. Exadaktylos, K. van Schooten, A. Ionescu, E. van Wegen, M. Rietberg, L. Kerckhaert, J. van Hilten, D. Hepp (Leiden, Netherlands)

  • Additive effect of Diabetes Mellitus and genetic risk variant in Parkinson’s Disease

    B. Tan, S. Chan, L. Chan, L. Tan, E. Tan (Singapore, Singapore)

  • Admixture Mapping of the VA Million Veteran Program Cohort Implicates Novel Genetic Risk Loci for PD Driven by African and Native American Ancestry

    O. Lorenzo-Betancor, T. Leal, V. Borda, T. Thornton, T. O'Connor, I. Mata, C. Zabetian (Seattle, USA)

  • Adolescent-onset Myoclonus Dystonia in MT-ND6 m.14487T>C–Associated Leigh Syndrome

    Y. Nishonova, S. Shokirov, I. Mazunin, O. Turgunkhujaev (Tashkent, Uzbekistan)

  • Adult hippocampal neurogenesis and cognitive and neuropsychiatric symptoms in Parkinson’s disease: the MemHiN study

    L. Batzu, A. Podlewska, S. Farmand, F. Derbyshire-Fox, A. Woods, N. Crane, C. Pariante, S. Thuret (London, United Kingdom)

  • Adult Onset Isolated Lower Limb Dystonia: Clinical Phenomenology and Dopaminergic Imaging Correlates

    P. Becker, N. Jeyakumar, S. Nagaratnam, T. Plinkert, F. Chang, H. Morales-Briceno, N. Mahant, S. Kim, A. Fois, D. Farlow, C. Bones Saunders, S. Evans, J. Galea, V. Fung (Sydney, Australia)

  • Adult-Onset Alexander Disease with Paroxysmal Myoclonus-Like Episodes and a Novel GFAP Variant

    G. Jung, H. Chang (Daejeon, Republic of Korea)

  • Adult-Onset Incomplete Kufor-Rakeb Syndrome Presenting with Parkinsonism: A Case Report

    L. Malfer, F. Onorati, E. Santoro, R. Savica (Rochester, USA)

  • Adult-Onset Opsoclonus-Myoclonus-Ataxia Syndrome Associated with West Nile Virus Mimicking a Functional Movement Disorder

    S. de Groot, M. Kalkach Aparicio, B. Lichter, M. Gabadadze, N. Amin, X. Yi, B. Madson (Sioux Falls, USA)

  • Adult-Onset Stereotypies and Cortical Myoclonus: An Unusual Presentation of Cerebral Amyloid Angiopathy

    N. Doan, T. Tran (Ho Chi Minh City, Viet Nam)

  • Advancing Mobility-Related Activities of Daily Living Monitoring in Parkinson’s Disease: A Systematic Review of Wearable Sensor Technologies

    S. Yamutai, R. Bhidayasiri, O. Phokeawvarangkul (Bangkok, Thailand)

  • Advancing Regular Non-motor Symptom Reporting During Inpatient Parkinson’s Disease Care Using a Self-Developed Digital Diary: A Three-Cohort Engagement Evaluation

    AJ. Wiederhold, NK. Wobito, C. Gundler (Hamburg, Germany)

  • Aerva Lanata Decoction Alleviates Neuroinflammation And Locomotor Dysfunction In Parkinson Model

    G. Chandran, B. Ramachandra (Mysuru, India)

  • Affective Symptom Burden in Individuals with Olfactory Dysfunction in the PREDICT-PD Cohort

    A. Shahid, S. Waters, S. Meyer, H. Chohan, V. Azoidou, C. Simonet, L. Pérez-Carbonell, E. De-Pablo Fernandez, A. Schrag, A. Noyce (London, United Kingdom)

  • Age of Onset as a Predictor of NonMotor Symptom Severity in Parkinson’s Disease

    PK. Manharlal, EC. Lim, SRJ. Ting, SE. Saffari, EK. Tan (Singapore, Singapore)

  • Age Related Susceptibility of Hippocampal Synaptic Ultrastructure and Spatial Cognition to Chronic Toluene Exposure: A Comparative Study of Immediate and Long Term Effects

    N. Pochkhidze, M. Zhvania, N. Japaridze (Tbilisi, Georgia)

  • Age-Dependent Peripheral Dissemination of α-Synuclein Seeds: Mechanistic Basis for Blood-Based Early Detection of Parkinson’s Disease

    K. Kuang (Guangzhou, China)

  • Age-Modulated Gait Adaptations to Progressive Fatigue in Parkinson’s Disease

    T. Bowman, D. Anastasi, C. Agliardi, P. Arcuri, F. Baglio, E. Calabrese, A. Castagna, M. Clerici, A. Crippa, E. Farina, S. Gobbo, FR. Guerini, F. La Rosa, M. Alberoni, C. Pagliari, A. Salvatore, M. Saresella, FL. Saibene, M. Meloni, D. Cattaneo (Milan, Italy)

  • Age-related characteristics of the clinical progression of Parkinson’s disease

    B. Muminov, R. Matmurodov, B. Amonov, S. Jumanazarova (Tashkent, Uzbekistan)

  • Age-Related Hearing Loss in Idiopathic Parkinson’s Disease and APOE E4 Carriers

    M. Kmiecik, C. Weldon, W. Xu, A. Guan, M. Mcintyre, R. Schneider, A. Auton, S. Aslibekyan (Palo Alto, USA)

  • Aggregation – Dependent Effects of Wild-Type and Mutant α-Synuclein on Synaptic Membrane Fusion

    M. Sriram, D. Rege, A. Das, R. Nellikka, D. Das (Mumbai, India)

  • Agreement Between Patient-Reported Experiences of Daily Living and Clinician-Rated Motor Exam Severity in Parkinson’s Disease

    A. Silva, M. Kalb, J. Agin-Liebes (New York, USA)

  • AI guided presurgical risk stratification for deep brain stimulation surgery

    J. Purks, J. Dwarampudi, R. Hu, T. Banerjee, J. Wong (Gainesville, USA)

  • AI-based Progression and Medication Response Prediction in Parkinson’s Disease: the AI-PMP Study Protocol

    N. Del Campo, S. Hadjidimitriou, C. Chatzichristos, O. Sánchez-Soliño, M. Kurtis, M. Almarcha-Menargues, B. Falkenburger, A. Saad, T. Strypsteen, C. Kyproula, P. Chairta, T. Scott Duncan, I. Gerasimou, A. Drif, N. Schnalke, E. de Pablo-Fernández, M. de Vos, O. Rascol, L. Hadjileontiadis, M. Fabbri (Toulouse, France)

  • AI-driven quantification of oro-facial dyskinesia and kinetic entropy as a predictive biomarker for recovery in paediatric anti-NMDAR encephalitis

    A. Datta, A. Mukherjee (KOLKATA, India)

  • All Left: A Case of Ipsilateral Stimulation Induced Dyskinesia

    P. Gupta, D. Vuddandam, A. Madamangalam, G. Kenworthy, J. Wong, L. Fanty (Gainesville, USA)

  • Allied Health Professionals in Movement Disorders: a survey of clinical practice and education needs across the world

    A. Sivaramakrishnan, A. Roberts, E. Tripoliti, L. Rochester, A. Nieuwboer, J. Dean (San Antonio, TX, USA, USA)

  • Allogeneic iPSC-Derived Dopaminergic Progenitor Transplantation for Parkinson’s Disease: A Phase 1, Dose-Escalation Trial

    D. Su, X. Wang, J. Zhang, X. Zheng, J. Luo, Z. Wang, L. Ma, J. Xi, P. Yan, X. Li, F. Meng, T. Feng (Beijing, China)

  • ALPHA-FIT: Slowing cognitive decline in alpha-synucleinopathies by enhancing physical activity

    E. Fitzgibbon, M. Wildt, T. Oosterhof, M. Rodemann, A. Ophey, E. Prins, S. Darweesh, A. Stefani, M. Sommerauer (Bonn, Germany)

  • Alpha-synuclein Seed Amplification Assay Set Up: Quality Control Using Standards and Controls

    B. Huxford, A. Noyce (London, United Kingdom)

  • Altered Degree Centrality and Its Association with Neurotransmitter Systems in Parkinson’s Disease Patients with Impulse Control Disorders: A Resting-State fMRI Study

    X. Wang, Y. Yuan (Nanjing, China)

  • Altered Diet–Microbiome Associations in Parkinson’s Disease and Prodromal REM Sleep Behavior Disorder

    S. Jo, J. Lee, H. Im, M. Choi, G. Lee, S. Chung (Seoul, Republic of Korea)

  • Altered Glia Limitans Structure and Function in Parkinson’s Disease and Multiple System Atrophy

    L. Wang (Shanghai, China)

  • Altered local synchronization and functional connectivity in Patients with Parkinson’s Disease

    DH. Lee (Wonju, Republic of Korea)

  • Altered Motor Regulation and Limbic-Motor Circuits in Paroxysmal Kinesigenic Dyskinesia

    XJ. Huang, ZY. Li, Y. Yuan, Y. Guan, Y. Li, L. Cao (Shanghai, China)

  • Ambulatory PEMF stimulation using the DCcure device improves rest and postural tremor in patients with PD

    I. Urman, M. Scheinowitz, R. Djaldetti (Petah Tiqva, Israel)

  • Ambulatory prognosis in spinocerebellar ataxia type 6: a single-center cohort study

    J. Nunomura (Aomori, Japan)

  • American Parkinson Disease Association Outreach to Mandarin-Speaking Communities in the United States

    E. Yao, V. Chan, R. Pena, R. Gilbert (Staten Island, USA)

  • Amyloid Burden in the Precuneus and Posterior Cingulate Gyrus Is Associated With Cognitive Function and White Matter Microstructure in Lewy Body Dementia

    H. Takeshige-Amano, N. Nishikawa, M. Osawa, H. Okada, D. Kamiyama, K. Onuki, S. Takemoto, K. Takabayashi, K. Kamagata, K. Murakami, T. Kato, T. Hatano, N. Hattori (Tokyo, Japan)

  • Amyloid PET–Guided Anti-amyloid Therapy in Corticobasal Syndrome Associated with Clinical Improvement

    S. Fujioka, Y. Nagaishi, T. Imamura, H. Minagawa, K. Uwatoko, M. Yukitake, J. Kira, Y. Tsuboi (Chiba, Japan)

  • Amyloid status as a moderator of the association between physical activity and progression of Parkinson’s disease

    MJ. Lee, K. Pak, M. Kim, JH. Lee (Busan, Republic of Korea)

  • An AI-Based Wearable Device Application To Assess Motor Skills Anomalies Associated with Parkinson’s Disease

    A. Ganu (San Jose, USA)

  • An artificial intelligence-based model to predict Parkinson’s disease risk: the AI-PRA study protocol.

    SV. Virameteekul, S. Hadjidimitriou, I. Gerasimou, C. Sotirakis, L. Hadjileontiadis, M. Almarcha-Menargues, B. Falkenburger, O. Sánchez-Soliño, K. Michailidou, M. Zanti, P. Chairta, K. Christodoulou, M. Kurtis, M. Fabbri, N. Del Campo, A. Noyce, E. de Pablo-Fernández (London, United Kingdom)

  • An Elevation in the Serum Biomarker pTau-181 May Identify Progressive Supranuclear Palsy Pathology

    K. Ramirez (Redwood City, USA)

  • An interesting case of progressive vision loss and unusual gait

    A. Kumar, S. Kumar (Patna, India)

  • An International Consensus Framework for Computer Vision-ready acquisition and reporting: Toward Measurement-grade video in Neurology

    J. Alty, G. Amprimo, J. Shin, M. Wuehr, M. Novotny, M. Merello, M. de Koning-Tijssen,, H. Haberfehlner, S. Relton, D. Wong, J. Taeger, A. Zwergal, S. Walther, B. Taati, R. Roemmich, C. Ferraris, M. Mckeown, A. Gupta, R. Li, M. Friedrich (Hobart, Australia)

  • An observational study of segmental and generalized isolated dystonia to inform development of new drug therapies

    M. Oldham, N. Lubarr, N. Carlson, T. Snyder, A. Wagle Shukla, H. Jinnah (Cambridge, USA)

  • An Ongoing Phase 1/2, Multi-center, Open Label Study of NouvNeu001 for the Treatment of Advanced Parkinson’s Disease

    M. Cai, J. Wei, X. Ren, R. Yan, H. Chen, N. Xiong (Chengdu, China)

  • An Optimized Workflow for High-Throughput RNA-Seq from Human Deep Brain Tissue Using DBS Microelectrodes

    S. Xxxx, A. Saini, V. Chouhan, S. Rai, D. Radhakrishnan, E. A, D. Garg, A. Das, S. Kumar, A. Yadav, A. Garg, R. Bhatia, A. Shariff, A. Srivastava, D. Savarakar, R. Kumar, M. Singh, K. Garg, P. Chandra, R. Rajan (New Delhi, India)

  • An unusual case of cerebellar ischemic stroke initially presenting as isolated hemifacial spasm without other neurological symptoms and signs

    WT. Yoon (Seoul, Republic of Korea)

  • An Unusual Cause Of Opisthotonus In A Young Female With Complete Recovery

    A. Rebello, S. A, P. Danda (Guntur, India)

  • Analysis of Genetic Variants Associated with Parkinson’s Disease and Depression

    D. Delgado-Gutiérrez, E. Gaspar-Martínez, J. Esquivias-Farias, I. Espinosa-Méndez, E. Fernández-Toledo, A. Medina-Rivera, P. Reyes-Pérez (Querétaro, Mexico)

  • Analysis of Sphingolipid Metabolism Gene Expression in the Parkinson’s Disease Postmortem Brain Dataset

    JL. Li, CH. Lin (New Taipei City, Taiwan)

  • Analyzing Perceived Effectiveness of Implemented Recruitment and Retention Strategies for Underrepresented Racial and Ethnic Groups in Parkinson’s Disease Clinical Trials

    P. Agarwal, I. Saraf, M. Park, J. Sanderson, F. Farrokhi, E. Bayram, M. Bruno, C. Tanner, N. Iturry, S. Mantri, M. Afshari, R. Amin, S. Aslam, R. Vasireddy, P. Auinger, K. Williams, C. Branson, R. Camicioli, I. Subramanian, J. Jimenez-Shahed (Kirkland, USA)

  • Analyzing the classification of 767 GBA1 variants to guide GBA1 PD risk prediction

    T. Böttcher, M. Radefeldt, C. Beetz, S. Schröder, S. Fischer, S. Oppermann, G. Kramp, J. Pinto Basto, P. Bauer (Rostock, Germany)

  • Anatomical and electrical field determinants of axial motor outcome after bilateral GPi-DBS in Parkinson’s disease

    M. Girija, C. Reddy, S. Joshua, A. Nair, A. Hynse, A. Kishore (Kochi, India)

  • Anhedonia in Parkinson’s Disease: Prevalence and Clinical Correlations

    Z. Sayfutdinkhuzhaev, I. Zhukova, N. Zhukova, G. Isroilova (Tomsk, Russian Federation)

  • ANK2 Mutations Associated with a Myoclonus-Dystonia Phenotype: Expanding the Neurological Spectrum of Ankyrin-B Dysfunction

    A. Lackova, M. Zech, J. Necpal, Z. Brezna, V. Han, K. Kulcsarova, M. Ostrozovicova, T. Svorenova, Z. Gdovinova, M. Skorvanek (Košice, Slovakia)

  • Ante-Mortem Motor Speech Profiles in Postmortem Confirmed Atypical Parkinsonisms

    N. Herndon, B. Patel, K. Hegland, O. Carranza-Renteria, S. Prokop (Gainesville, USA)

  • Anti Tremorgenic Properties Of Eslicarbazepine Acetate in The Harmaline Induced Tremor Mouse Model

    A. Coelho, A. Evrard, C. Roucard, T. Fonseca, V. Di Foggia, P. Soares-da-Silva, J. Holenz, N. Pires (São Mamede do Coronado, Portugal)

  • Anti-Amphiphysin Stiff-Person Spectrum Disorders: A Case Series Highlighting an Unusual Isolated Upper-limb Presentation and Systematic Review

    AL. Lee, D. Garg, JP. Schee, AMF. Dy Closas, JWY. Tee, ESY. Wong, KJ. Goh, MH. See, MS. Tai, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

  • Anti-IgLON5 Encephalitis Presenting as Chronic Progressive Asymmetrical Ataxia and Chorea

    P. Kosiyakul, J. Jitprapaikulsan, Y. Pitakpatapee (Bangkok, Thailand)

  • Anti-IgLON5 testing in movement disorder clinical practice: Observational cohort study and systematic review

    M. Carta, B. Vlad, L. Helbig, S. Kazanci, E. Boudriot, M. Raeber, B. Balint (Zurich, Switzerland)

  • Anti-mGluR5 Antibody-Mediated Chorea Secondary to Gastric Cancer: A case report

    M. Niedbalski, F. Urbina, M. Canals (Santiago, Chile)

  • Anticipatory Language Prediction ERPs Detect Early Neurophysiological Changes in Asymptomatic Huntington’s Disease

    A. Puig-Davi, L. Perez-Carasol, C. Franch-Marti, J. Perez-Perez, G. Olmedo-Saura, J. Rodriguez-Antiguedad, L. Bojtos, I. Ruiz-Barrio, J. Pagonabarraga, J. Kulisevsky, S. Martinez-Horta (Barcelona, Spain)

  • Antidepressants in Huntington’s Disease: A Meta Analysis of Mood and Motor Outcomes with Placebo-controlled Trials

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

  • Antimicrobial Use and Risk of Parkinson’s Disease: A Swedish National Case-control Study

    S. Licaj, A. Ploner, M. Szilcz, J. Wastesson, S. Hägg, F. Fang, K. Wirdefeldt (Solna, Sweden)

  • APOSTIM study: a prospective study on quality of life in Parkinsonian patients sequentially treated with apomorphine infusion and STN stimulation

    F. Fluchere, S. Drapier, C. Moreau, F. Ory-Magne, E. Hainque, A. Marques Gagniere, B. Jarraya, S. Thobois, S. Ansquer, C. Giordana, D. Guehl, S. Frismand, T. Rouaud, M. Tir, A. Roland, D. Devos, A. Eusebio, JP. Azulay (Marseille, France)

  • App-Based Speech Assessment Differentiates PD and PSP: A Feasibility Study in Italian Speakers

    T. Thies, S. Cuoco, M. Autuori, A. Sahay, J. Tröger, M. Picillo (Saarbrücken, Germany)

  • Apparent Change Classification with Stage-Specific and Fixed Minimal Detectable Change Thresholds in Parkinson’s Disease

    R. Yamasaki, Y. Inoue (Kurashiki, Okayama, Japan)

  • Application of the MDS Nonmotor-Symptom Questionnaire in Evaluation of Deep Brain Stimulation Candidates.

    T. Turner, S. Crowley (charleston, USA)

  • Archimedes Spiral and Straight-Line Drawings as Digital Biomarkers in Cerebellar Ataxia: A Preliminary Study

    K. Tsutsumi, J. Martin, S. Pavani, S. Attaripour Isfahani (Orange, USA)

  • Are All Toxins Created Equal? Real-world analysis of Abo-, Inco- and Ona- BoNT-A from prospective LIVEchart over 7 years

    R. Ellis, A. Moore (Liverpool, United Kingdom)

  • Are we overlooking wearing off? Evaluating the role of the WOQ-9 questionnaire in routine Parkinson’s care

    G. Heery, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)

  • Arm Swing and Early Gait Characteristics in Parkinson’s Disease

    C. Aaen, M. Vendelhaven, A. Behrndtz, M. Stilund, A. Terkelsen, E. Danielsen, E. Johnsen, M. Møller, W. Sloth, J. Brincks, J. Phan (Horsens, Denmark)

  • Artificial Intelligence-Based Voice Analysis for Early Detection of Parkinson’s Disease: A Systematic Review

    O. Uwishema (Kigali, Rwanda)

  • Assessing Agreement of Self-Perception of Dysphagia in Individuals with Parkinson Disease and their Caregivers

    A. Silbergleit, L. Schultz (West Bloomfield, USA)

  • Assessing an inclusive online lifestyle-based intervention program that supports British Columbians living with chronic neurological conditions, their care partners and healthy agers

    A. Hashimoto, S-A. Stelling, S. Appel-Cresswell (Vancouver, Canada)

  • Assessing Concordance Between Clinical judgment And 5-2-1 Criteria In Advanced Parkinsons Disease

    A. Subramaniam, M. Mann, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)

  • Assessing the Effects of Anti-Parkinsonian Medication Using Wearable Sensor-Derived Kinematic Data and Machine Learning

    A. Siekmann, C. Sotirakis, J. Huxley, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

  • Assessing the Feasibility of a Multimodal Control Model for Deep Brain Stimulation in Parkinson’s Disease: A Structured Literature Review

    J. Dubuclet, Y. Pathak (Plano, USA)

  • Assessing The Role Of Afg3l2 Pathogenic Variants In Parkinson’s Disease

    V. Quintana-Peña, I. Keller Sarmiento, B. Bustos, L. Lange, K. Lohmann, R. Alcalay, M. Marti, N. Okubadejo, S. Lim, T. Foroud, R. Kaiyrzhanov, E. Valente, R. Krüger, H. Morris, B. Jeon, C. Klein, J. Trinh, N. Mencacci (Chicago, USA)

  • Assessment of Demographic and Clinical Characteristics of Early- and Late-Onset Parkinson’s Disease in Bangladesh.

    T. Zannat, K. Dey, A. Haque, A. Zirra, E. Camboe, D. Mair, S. Waters, S. Ali, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh, Bangladesh)

  • Assessment of dysautonomia in patients with sporadic adult-onset ataxia

    N. Joksimović, N. Mazalica, N. Krstić, U. Lazić, A. Milovanović, I. Pavlović, N. Dragaševic, I. Stanković (Belgrade, Serbia)

  • Assessment of GCA repeat expansion in the GLS gene among Indian patients with Spinocerebellar Ataxia

    V. Suroliya, M. Kumar, B. Uppili, AK. Srivastava, M. Faruq (Gurugram, India)

  • Assessment of Postural abnormalities in Early-stage Parkinson’s Disease Using a Posture Analyzing and Virtual Reconstruction Device

    HW. Yang, SI. Choi, WH. Lee, NY. Kim (Yongin, Republic of Korea)

  • Assessment of α-Synuclein Seeding Activity in the Olfactory Mucosa after SARS-CoV-2: a Pilot Study

    B. Heim, K. Seppi, N. de Cleene, M. Bongianni, E. Bronzato, C. Cerejo, F. Jagusch, P. Kindl, J. Loeffler-Ragg, G. Weiss, T. Gottfried, J. Schmutzhard, G. Zanusso, W. Poewe (Innsbruck, Austria)

  • Association Between Esophageal Motility and Gait in Parkinson’s Disease: Possible Differential Mechanisms by Esophageal Region

    JY. Lee, SH. Kim, SB. Koh (Seoul, Republic of Korea)

  • Association Between Liver Function and Motor Symptoms in Parkinson’s Disease: A Cross-cohort Analysis of Chinese and PPMI patients

    Y. Wang, X. Zheng, X. Liu, C. Li (Chengdu, China)

  • Association between probable RBD and reduced CSF 5-hydroxyindoleacetic acid levels in Parkinson’s disease

    K. Hatano, M. Kameyama, M. Kurihara, A. Iwata (Tokyo, Japan)

  • Association between Sleep Behaviors and Age at Onset of Parkinson’s Disease

    N. Zhou, M. Fang, L. He, T. Shao, Z. Liu, B. Liu, R. Li, W. Li (Beijing, China)

  • Association Between Sleep Disturbance and Fatigue in Patients with Parkinson’s Disease

    K. Kurihara, N. Takahashi, K. Inoue, J. Tsugawa, Y. Baba (Fukuoka, Japan)

  • Association between Smoking and LRRK2 Variants on Parkinson’s Disease Risk

    JDJ. Wang, LL. Chan, E. Ng, KM. Prakash, L. Tan, EK. Tan (Singapore, Singapore)

  • Association Between Step Count Change Rate During Dual Task Timed Up and Go and Balance Components in Parkinson’s Disease

    Y. Yamazaki, T. Nakamura, K. Watanabe, G. Horiguchi, S. Kishimoto, H. Miyamoto, Y. Kameyama, E. Kitahara, K. Haruyama, N. Nishikawa, T. Hatano, N. Hattori, T. Fujiwara (Bunkyo-ku, Japan)

  • Association Between the Side of Tremor Onset and Clinical Profiles of Patients with Parkinson’s disease in Rural and Urban Tanzania

    K. Okeng'O, W. Walker, N. Okubadejo, P. Adebayo, N. Fothergill-Misbah, M. Dekker, B. Mushengezi, G. Lyimo, E. Massawe, M. Mng'Ong'O, J. Silvester, S. Urasa (Dar es salaam, United Republic of Tanzania)

  • Association of Benign Prostatic Hyperplasia With Incident Parkinson’s Disease in Men: A Prospective Cohort Study From the UK Biobank

    Y. Yu, X. Zheng, Y. Wang, X. Liu, H. Shang, C. Li (Chengdu, China)

  • Association of Coffee Consumption and Smoking with Cognitive Function in Patients with Early Parkinson’s Disease

    SM. Choi, HL. Lee (Gwangju, Republic of Korea)

  • Association of DAGLB Variants with Early-Onset Parkinson’s Disease Across Populations

    Y. Mecheri, W. Kamel, E. Eltaraifee, A. Olusanya, N. Kuznetsov, GP2. Genetic Program, T. Perinan (Constantine, Algeria)

  • Association of Glymphatic Flow at Diffusion Tensor Image with Motor Symptoms and Striatal Dopamine Degeneration in Parkinson’s Disease

    SJ. Chung, CJ. Park, PH. Lee, YH. Sohn, YJ. Kim (Seoul, Republic of Korea)

  • Association of IL-6 and Lp(a) with Incidental Parkinson’s Disease Risk and Motor Severity After Stroke: A Prospective Cohort Study

    Z. Zhu, H. Wang, Y. Geng, Z. Yin, Y. Xu, M. Xu, J. Shi, Y. Yuan, K. Yi, D. Geng, K. Zhang (Nanjing, China)

  • Association of MT-ATP6 Polymorphisms with Increased Reactive Oxygen Species and Biomarker Alterations in Parkinson’s Disease

    B. Chandar, HSB. Suresh Babu, NR. Raj, MB. Balachandar, VL. Lakhanpal (Bathinda, India)

  • Association of Neurofilament Light Chain with Substantia Nigra Degeneration in Parkinson’s Disease

    WJ. Wu, WQ. Jiang, QY. Zheng, L. Luo, Y. Zhang, XY. Zhang, ZM. Dong, ZY. Yu, T. Wu, XJ. Dai, DL. Zhang (Beijing, China)

  • Association of one-year group-based telerehabilitation with quality of life in Parkinson’s disease

    H. Saegusa, S. Okusa, T. Nukariya, T. Tezuka, Y. Nihei, Y. Kitagawa, S. Kubo, Y. Terayama, N. Suzuki, J. Nakahara, M. Seki (Tokyo, Japan)

  • Association of Quality of Life with Risk Markers and Prodromal Signs of Parkinson’s Disease in the Population-Based Healthy Brain Ageing Study

    N. Peña Arauzo, C. Pauly, SR. Jonsdottir, C. Theyer, L. Zamarian, C. Horlings, S. Leiter, W. Poewe, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, DF. Pilco-Janeta, A. Garrido, F. Farfan, V. Satagopam, S. Ghosh, K. Rege, A. Noyce, P. Mahlknecht (Innsbruck, Austria)

  • Association of Riverine Heavy Metal Contamination with Parkinson’s Disease Risk in Rural Pune: A Population-Based Case-Control Study

    A. Gangadhar, Y. Dayma (Pune, India)

  • Association of Sarcopenia with Fear of Falling and Falls in patients with Parkinson’s disease

    I. Dagklis, D. Kazis, S. Bostantjopoulou (Thessaloniki, Greece)

  • Association of Serum Linoleic Acid-containing Plasmalogens With Parkinson’s Disease: the PPMI Study

    D. Wang, Y. Liu (Jinan, China)

  • Association of the GCH1 p.Ser80Asn variant with Parkinson’s disease in East Asian populations

    YW. Tay, AL. Lee, JP. Schee, CH. Lin, EK. Tan, JH. Shin, PS. Chen, E. Ng, HJ. Kim, BS. Jeon, I. Sarmiento, M. Periñan, L. Lange, P. Heutink, K. Lohmann, C. Klein, N. Mencacci, SY. Lim, A. Ahmad Annuar, AH. Tan (Kuala Lumpur, Malaysia)

  • Association of Triglycerides, LDL, and IL-6 with Non-Motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study

    F. de Amor, S. Suryadi, E. Pasmanasari, A. Wati (Semarang, Indonesia)

  • Association study of genetic variants with Essential Tremor

    B. Tan, E. Ng, Q. Sun, K. Prakash, L. Tan, E. Tan, B. Xiao (Singapore, Singapore)

  • Associations Between FDG-PET Regional Metabolism and Clinical Severity in Progressive Supranuclear Palsy

    M. Oliveira, V. Maciel, G. Martins, C. Carneiro, C. Buchpiguel, A. Coutinho, J. Parmera, E. Barbosa (São Paulo, Brazil)

  • Associations Between Saccadic and Motoric Symptoms in Parkinson’s Disease

    M. Gibbs, A. D'Souza, C. Sotirakis, T. Crawford, C. Antoniades (Oxford, United Kingdom)

  • Associations of Accelerated Biological Aging With Parkinson’s Disease

    L. Luo, M. Wang, T. Ai, Q. Zheng, W. Wu, Y. Wang, T. Wu, Y. Pan, D. Zhang (Beijing, China)

  • Astrocyte Derived Extracellular Vesicle miR 210 Expression in Exenatide Treated Patients with Parkinson’s Disease

    A. Keshavaprasad, I. Markaki, P. Svenningsson, S-B. Catrina, X. Zheng (Linköping, Sweden)

  • Ataxia as the Primary Symptom of Leber Hereditary Optic Neuropathy: A Case Report of a Patient and Family Observation

    D. Korotkova, M. Karpova (Chelyabinsk, Russian Federation)

  • Attention-Enhanced Deep Learning for Midbrain MRI Segmentation in Parkinson’s Disease

    C. Mahapatra, S. Swain (Powai, India)

  • Atypical Parkinson: what can an outpatient Voice and Swallowing Clinic offer to patients

    E. Iliadou, I. Siklafidou, M. Tola, L. Stefanis, E. Tripoliti (Athens, Greece)

  • Atypical Phenotype of SORL1-Associated Early-Onset Alzheimer’s Disease With Oromandibular and Cervical Dystonia

    M. Danis, G. Krastev (Trnava, Slovakia)

  • Atypical vascular parkinsonism from a midbrain lesion with excellent dopaminergic response

    WW. Lee (Seoul, Republic of Korea)

  • Audit of Diagnostic Standards in the Dystonia Clinic

    E. Ryder, V. Lafort, O. Killian, C. Fearon, S. O'Riordan, L. Williams (Dublin, Ireland)

  • Augmenting PD GENEration Genotyping with Continuous Digital Monitoring for Parkinson’s Disease

    A. Hare, J. Beck, C. Blauwendraat, K. Galvelis, R. Gilron (San Francisco, USA)

  • Auricular Symptoms in Cervical Dystonia: A Case Series

    H. Ooi, H. Sarva, P. Garcia-Ruiz, E. Gatto (New York, USA)

  • Autoimmune Movement Disorders Presenting With Functional Phenotypes Diagnostic Pitfalls and Red Flags

    M. Kakde, S. Kakde, S. Kakade (Pune, India)

  • Automated Closed-Loop DBS Using AI Decoding in Parkinson’s Disease: A Systematic Review and Meta-Analysis of UPDRS-III Improvements in tremor, bradykinesia and Motor Fluctuations.

    A. Gunasekar, M. Ahmad, M. Thavasi, P. Subburaj, M. Venkastesan, S. Sv, A. Soroush, K. Prakash Meena, R. Ramananthan, R. Vignesh, J. Srirangaramasamy, B. Kamaraj (Thriuvallur, India)

  • Automated CRST Spiral Drawing Scoring Using a Multimodal Vision-language model: Development and Validation in a Large Essential Tremor Cohort

    C. Reddy, A. Zoana, M. Lotia, N. Reddy, A. Ahmed, J. Ledoux, P. Nonat, R. Guevarra (Celebration, USA)

  • Automated differential diagnosis of Parkinson’s disease and Parkinson-like disorders via motion capture analysis

    W. Sako, M. Osawa, T. Hara, T. Iguchi, H. Haginiwa, S. Haji, T. Hatano, N. Hattori (Tokyo, Japan)

  • Automated Differentiation for Early Parkinsonism Using Clinical Structural MRI: A Multicenter Study

    LC. Zhou, CZ. Wang, AL. Du, J. Liu, J. Wang (Shanghai, China)

  • Automated dystonic posture detection of the hand in children with GNAO1-related movement disorders from home-based videos using computer vision

    L. Heideman, M. Vander Krogt, S. Vander Ven, N. Wolf, A. Buizer, L. Vande Pol, H. Haberfehlner (Amsterdam, Netherlands)

  • Automated Facial Movement Analysis for Differentiating True Hemifacial Spasm from Mimicking Facial Movements: A Pilot Study

    S. Maytharakcheep, A. Saeng-Xuto, P. Songthung, D. Surangsrirat, P. Vateekul, R. Bhidayasiri, O. Phokaewvarangkul (Bangkok, Thailand)

  • Automated Identification of Freezing of Gait in Parkinson’s Disease Using Q-Learning Analysis during Virtual Reality–Based Gait Task

    K. Seo, M. Hara, S. Alaoui, T. Yamamoto, G. Oyama (Saitama, Japan)

  • Automated Image-guided Programming for DBS Matches Expert Clinician Programming

    H. Lee, E. Crawford, R. Anderson, J. Dicicco, P. Stepan, R. Bargloski, M. Gourley (Sacramento, USA)

  • Automated MRI Biomarker Extraction for Parkinson’s Disease Using Attention-Based U-Net Segmentation

    G. Kuanar, C. Mahapatra (Cuttack, India)

  • Automated Speech Analysis for the Differentiation of Multiple System Atrophy from Parkinson’s Disease in an English-Speaking Cohort

    E. Ní Chonchúir, C. Espinoza Vinces, X. Yang, C. O'Keeffe, J. Inocentes, A. Gill, C. Fearon, R. Reilly (Dublin, Ireland)

  • Automated Video-Based Assessment of Lip Articulation in Parkinson’s Disease

    J. Strelow, T. Thies, I. Rubi-Fessen, M. Barbe, D. Mücke (Cologne, Germany)

  • Automatic Detection of Freezing of Gait from Simple, 2D Video Recordings in Complex Clinical Environments

    A. Shakolnikov, O. Perlman, J. Hausdorff (Tel Aviv-Yafo, Israel)

  • Automatic Segmentation of the Subthalamic Nucleus and Globus Pallidus Internus: Can it support planning and programming in Deep brain stimulation

    T. Maiti, S. Mittal, C. Ugas (Abu Dhabi, United Arab Emirates)

  • Autonomic Coupling Patterns Differ by REM Sleep Behavior Disorder Status in De Novo Parkinson’s Disease

    B. Jin, J. Kim, S. Cheon (Busan, Republic of Korea)

  • Awareness about Movement Disorders among Ukrainian Neurologists

    Y. Trufanov, N. Khanenko, M. Trishchynska, Y. Tarasenko, T. Voronova-Smolyannikova, A. Galusha, N. Pavliuk, A. Ovchynnykova, R. Sulik, V. Sereda, L. Zviahina, A. Babirad, K. Bakum, V. Dubynetska, V. Yevdokymov, A. Mykhailenko, K. Moisieieva, Z. Tyzhuk, N. Vintoniv-Trushyk, Y. Compta (Kyiv, Ukraine)

  • Axial parkinsonism after 15 years of pallidal stimulation in generalized dystonia

    C. Desjardins, C. Bonnet, E. Moro, D. Grabli, V. Fraix, ML. Welter, S. Navarro, C. Karachi, S. Raoul, M. Guibourd, E. Cuny, S. Chabardes, P. Burbaud, D. Guehl, P. Derkinderen, M. Vidailhet (Paris, France)

  • Axonal-demyelinating polyneuropathy after subcutaneous foslevodopa/foscarbidopa infusion – case report.

    D. Przewodowska, S. Szlufik, L. Milanowski, M. Figura, D. Koziorowski (Warsaw, Poland)

  • Azathioprine-associated changes in peripheral–central immune signalling in Parkinson’s disease: post-hoc analysis of AZA-PD

    J. Greenland, J. Holbrook, R. Pal, L. Kahanawita, K. Dresser, E. Cutting, C. Williams-Gray (Cambridge, United Kingdom)

Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley